C M Botelho1, R A Brooks, S M Best
1INEB- Instituto de Engenharia Biomédica, Laboratório de Biomateriais, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study examined how silicon-substituted hydroxyapatite (HA) affects human osteoblast behavior in culture. Researchers compared pure HA with two silicon-substituted versions (0.8 wt% and 1.5 wt%). They found that 1.5 wt% silicon-substituted HA increased alkaline phosphatase production at day 7. Hydrocortisone addition promoted cell differentiation but reduced osteocalcin levels. After hydrocortisone removal, cells on 0.8 wt% silicon-substituted HA showed increased protein production. Tetracycline-labeled nodules formed on all substrates after 21 days, unrelated to silicon content. The findings suggest that silicon content in HA substrates influences osteoblast behavior in a time-dependent manner.
Area of Science:
Background:
The field of biomaterials research has long sought to understand how surface composition influences cell behavior. Prior research has shown that hydroxyapatite (HA) is widely used in bone regeneration due to its similarity to natural bone mineral. However, the impact of trace element substitutions in HA remains unclear. Some studies have suggested that silicon incorporation may alter cell adhesion or differentiation. Yet, the specific effects of silicon substitution on osteoblast activity have not been fully resolved. This uncertainty drives the need for controlled in vitro experiments. The role of silicon in modulating osteoblast function is still debated. Existing literature lacks detailed time-course data on silicon-substituted HA effects. This gap motivates investigations into how silicon content influences osteoblast phenotypes.
Purpose Of The Study:
This study aimed to evaluate how varying silicon content in hydroxyapatite substrates affects human osteoblast behavior. The specific problem addressed is the lack of clarity regarding optimal silicon substitution levels for bone-forming cell activity. Researchers sought to determine if silicon substitution promotes osteoblast differentiation or mineral production. The motivation stems from the need to optimize implant materials for bone regeneration. The study tests whether silicon enhances osteoblast responses compared to pure HA. The timing of observed effects is also a key focus. The goal is to identify how silicon levels influence protein production and mineral deposition. This work contributes to the broader effort of improving biomaterials for orthopedic applications.
At day 7, 1.5 wt% Si-HA showed significantly higher alkaline phosphatase production compared to HA and 0.8 wt% Si-HA.
Hydrocortisone addition promoted cell differentiation on HA and 0.8 wt% Si-HA substrates but decreased osteocalcin production.
After hydrocortisone removal, cells on 0.8 wt% Si-HA showed a significant increase in protein production, suggesting a time-dependent effect.
Fluorescence microscopy showed tetracycline-labeled nodules on all substrates after 21 days, unrelated to silicon content.
Main Methods:
Human osteoblasts were cultured on three types of substrates: pure hydroxyapatite, 0.8 wt% silicon-substituted HA, and 1.5 wt% Si-HA discs. Cell behavior was monitored through protein content measurements in cell lysates. Researchers assessed phenotypic markers including collagen type I, alkaline phosphatase, and osteocalcin. Bone mineral formation was also quantified during the experiment. After seven days, beta-glycerophosphate and hydrocortisone were added to stimulate differentiation. Fluorescence microscopy was used to observe tetracycline-labeled nodular structures. The study tracked changes in protein and mineral production over time. The experimental design compared responses across all three substrate types systematically.
Main Results:
At day 7, 1.5 wt% Si-HA showed significantly higher alkaline phosphatase production compared to other substrates. Hydrocortisone addition promoted cell differentiation on HA and 0.8 wt% Si-HA substrates. However, hydrocortisone decreased osteocalcin production across all groups. After hydrocortisone removal, cells on 0.8 wt% Si-HA showed increased protein production. No significant differences were observed between HA and Si-HA during hydrocortisone exposure. Tetracycline-labeled nodules formed on all substrates after 21 days. These nodules appeared in high cell density regions but were unrelated to silicon content. The results suggest silicon influences osteoblast behavior in a time-dependent manner.
Conclusions:
The study demonstrates that silicon substitution affects osteoblast behavior in a time-dependent manner. The presence of silicon in HA substrates alters alkaline phosphatase production at day 7. The effect of silicon becomes more pronounced after hydrocortisone removal. No significant differences were observed during hydrocortisone treatment. The formation of tetracycline-labeled nodules was consistent across all substrates. These findings suggest silicon content may influence osteoblast differentiation timing. The study supports the idea that silicon substitution could be used to modulate cell responses. The authors propose that silicon content should be considered when designing biomaterials.
The study measured bone mineral formation through tetracycline-labeled nodules observed via fluorescence microscopy.
The authors propose that silicon content in HA substrates could be used to modulate osteoblast behavior in a time-dependent manner.